Picture of Valbiotis SA logo

ALVAL — Valbiotis SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Valbiotis H1 Revenue Up At 121,000 Euros

Sept 30 (Reuters) - VALBIOTIS SA  ALVAL.PA :
    * HALF YEAR NET LOSS -2.931 MILLION EUR
    * H1 REVENUE 121,000 EUR
    * A CASH POSITION OF EUR 10.9M AT JUNE 30, 2020, NOT
INCLUDING
FINANCING OBTAINED SINCE THIS DATE, I.E. NEARLY EUR 8M
    * OPERATING INCOME AMOUNTED TO EUR 714K
    * IN FIRST HALF OF YEAR, RESEARCH AND DEVELOPMENT EXPENSES
DECREASED BY 8% COMPARED TO SAME PERIOD LAST YEAR, TO EUR 1,939K
    * H1 NET RESULT LOSS OF EUR 2.9 MILLION
    * HAS CARRIED OUT A SPECIFIC REVIEW OF ITS LIQUIDITY AND
CONSIDERS
THAT IT DOES NOT FACE ANY SHORT-TERM RISK
    * AS OF TODAY, END OF CASH FLOW IS ESTIMATED TO BE IN FIRST
HALF
OF 2022

Source text for Eikon:  ID:nBw3nbn6la 
Further company coverage:  ALVAL.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Valbiotis SA

See all news